The Richmond Club

AzurRx BioPharma, Inc.

Biotech — is developing non-systemic oral biologics to treat patients with gastrointestinal disorders. Focused on developing its lead drug product candidate, MS1819, a recombinant lipase enzyme that treats exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis. AzurRx is headquartered in New York, NY, with scientific operations in Langlade, France, and clinical operations in Hayward, California.

AzurRx is listed on the NASDAQ under the symbol AZRX.

Three reasons to invest in AzurRx Pharma 

  1. The company has a strong patent family — with more than one patent, the company has a pipeline of intellectual property to fuel its growth. 
  2. The market is sizeable, worth well over US$2 billion — the company believes it could capture 40 to 50 per cent of this market share.  
  3. The stock is significantly undervalued — most of AzurRx’s peers are trading at three to four times their sales revenue. 


 2 Minute Company Overview

Play Video

For more information about AzurRx BioPharma, please contact Martin Krusin, SVP of Corporate Development at (646) 713-2924

 CEO interview

Play Video

 Investor presentation

Play Video

Subscribe To The Richmond Club News

The Richmond Club

All Rights Reserved © 2020

Get Access to The Richmond Clubs Latest Stock Picks For FREE!


Don’t miss your chance to get in on the top stocks we think are the best buys now inside our exclusive Richmond Club Stock Advisor Letter.

Led by Chartered Investment Manager, Greg Beckett, the average stock pick inside The Richmond Club is up 1,301% vs. just 153% for the S&P.

This is your opportunity to become part of an exclusive membership led by the Richmond Club that has seen an average of 16.45 % gains over the past 15 years!

If you want to take advantage of this buying opportunity, simply enter your email address below to access our secure sign-up page.

Join The Richmond Advisor Free For 2-Months

By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy